Literature DB >> 17292492

N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction.

Nahoko Ikeda1, Takanori Yasu, Toshio Nishikimi, Tomohiro Nakamura, Norifumi Kubo, Masanobu Kawakami, Shin-ichi Momomura, Muneyasu Saito.   

Abstract

BACKGROUND: Left ventricular end-diastolic pressure (LVEDP) during exercise workload is an important parameter to guide an exercise prescription for patients with cardiovascular disease. Plasma levels of neuro-hormonal factors can be used as a reflection of real-time LVEDP, but its utility is limited by its short half-life. By contrast, the N-terminal fragment of pro-ANP (NT-ANP) has a longer half-life of 1 h.
OBJECTIVE: To determine whether plasma NT-ANP levels at 30 min after exercise can be used as a marker of LVEDP during peak exercise workload in patients with previous myocardial infarction. PATIENTS: Twenty patients with a previous history of myocardial infarction.
INTERVENTIONS: Cardiopulmonary exercise test was performed to determine peak VO(2) and anaerobic threshold. Plasma levels of ANP, BNP, NT-ANP, vasopressin and plasma catecholamine were measured at rest, maximum exercise, and 30 min after exercise (recovery).
RESULTS: With the exception of NT-ANP, the levels of each of neuro-hormonal factors peaked at maximum exercise and returned to baseline at recovery. By contrast, NT-ANP levels also increased at peak exercise but remained elevated at 30 min after exercise. Furthermore, NT-ANP levels at recovery correlated with ANP levels at maximum exercise (p<0.01, R=0.75), left ventricular ejection fraction (p<0.02, R=-0.54) and left ventricular systolic dimension (p<0.015, R=0.50).
CONCLUSION: Plasma NT-ANP levels at 30 min after exercise reflect ANP levels at maximum exercise and left ventricular overload during exercise. These data indicate that plasma NT-ANP after exercise may be a useful parameter to guide prescription of cardiac rehabilitation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292492     DOI: 10.1016/j.regpep.2006.12.024

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  3 in total

1.  Involvement of the atrial natriuretic peptide in cardiovascular pathophysiology and its relationship with exercise.

Authors:  Júlio C de Almeida; Clodoaldo L Alves; Luiz Carlos de Abreu; Monica A Sato; Fernando L Fonseca; Carlos B de Mello Monteiro; Luiz Carlos M Vanderlei; Hugo Macedo; Carlos M Tavares; Dafne Herrero; Luciano Mr Rodrigues; Vitor E Valenti
Journal:  Int Arch Med       Date:  2012-02-07

Review 2.  Can biomarkers help to diagnose early heart failure with preserved ejection fraction?

Authors:  Jaroslav Meluzín; Josef Tomandl
Journal:  Dis Markers       Date:  2015-01-31       Impact factor: 3.434

3.  Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms.

Authors:  Seiji Takashio; Hiroyuki Takahama; Toshio Nishikimi; Tomohiro Hayashi; Chiaki Nagai-Okatani; Ayaka Matsuo; Yasuaki Nakagawa; Masashi Amano; Yasuhiro Hamatani; Atsushi Okada; Makoto Amaki; Takuya Hasegawa; Hideaki Kanzaki; Satoshi Yasuda; Kenji Kangawa; Toshihisa Anzai; Naoto Minamino; Chisato Izumi
Journal:  Open Heart       Date:  2019-07-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.